CheckMan Stock Market Overview

Qualcomm ​is expected to use its investor day on Wednesday to lay out ‌a push beyond its core smartphone business into the fast-growing, but highly competitive, market for AI data center chips.

INTC is gaining traction in sovereign AI as TPIsoftware adopts Xeon 6 and Arc Pro B60, opening more AI infrastructure exposure across Asia-Pacific.

Vancouver, British Columbia – June 24, 2026 - TheNewswire – Majestic Gold Corp. (TSX.V: MJS, FSE: A0BK1D) (the “ Company ”) is pleased to announce that the Supreme Court of British Columbia (the “ Court ”) has issued a decision in respect of an application brought in a petition proceeding initiated by Mr. Fan Zhong Kong seeking, among other relief, an interlocutory injunction delaying the Company from completing the non-brokered private placement announced on May 21, 2025 (the “ Private Placement ”) until after Mr. Kong's petition is decided on its merits or until after the Company's annual general meeting of shareholders scheduled to be held on July 31, 2026 (the “ AGM ”). The Court declined to order this relief. On an interlocutory basis, the Court has directed that the Private Placement may close after the record date for the AGM, which is June 29, 2026. The Company intends to close the Private Placement as expeditiously as possible.

Micron Technology (NASDAQ:MU | MU Price Prediction) has gone vertical.

Worthington Enterprises, Inc. (WOR) Q4 2026 Earnings Call Transcript

Shares of tech giant Apple Inc. NASDAQ: AAPL are trading just under $300 this week, as they continue to bounce off their low from earlier this month and move back towards the all-time high they hit a few weeks ago.

KB Home NYSE: KBH is not out of the weeds, with its revenue contracting, orders and backlog declining, and margins under pressure, but these forces are already priced into its stock. Housing market woes, inflation, and high interest rates are no secret.

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCE® (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) locally advanced or metastatic breast cancer (MBC) following induction treatment. The approval is based on positive results from.

Tom Lee, Head of Research at Fundstrat Global Advisors, used a CNBC appearance on June 24, 2026 to argue that the latest sharp semiconductor pullback is the kind of dislocation long-term buyers should welcome.

The gold market is struggling to hold support at $4,000 an ounce, and although this has been a critical level of focus in recent weeks, analysts say that the current bear-market correction should not signal the end of the long-term bull market.